Triofan Rhinitis retard, capsules

7680334450011 CH-33445 Kapseln

Associated product:

TRIOFAN rhinite retard caps 10 pce
Triofan Rhinitis retard, capsules
Triofan Rhinitis retard, capsules
Triofan Rhinitis retard, capsules
1 / 3
google

Article details

Package size
10
Selling units
10
Measure
Kapsel(n)
Galenic form
Kapseln
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
27/09/2023
Patient information leaflet
Français
27/09/2023
Patient information leaflet
Italien
27/09/2023
Summary of Product Characteristics
Allemand
07/09/2021
Summary of Product Characteristics
Français
07/09/2021
Summary of Product Characteristics
Italien
07/09/2021

Detailed composition

Substance Quantity Type Category
(N/A)
4.0 MG Substance Wirkstoff (Principe actif)
(N/A)
20.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FIMDK
(N/A)
- Substance FIMDK

Authorization holder

Verfora SA

1752 Villars-sur-Glâne

Authorization information

Swissmedic authorization number
33445
Drug name
Triofan Rhinitis retard, capsules
Galenic form
RETH
ATC Code
R01BA53
Authorization status
Z
Dispensing category
D
First authorization
15/11/1968
Authorization expiration date
31/12/9999
IT Number
12.02.6.
Domain
Human medicine

Package details

Description (FR)
TRIOFAN rhinite retard caps 10 pce
Description (DE)
TRIOFAN Rhinitis retard Kaps 10 Stk
Market launch
15/11/1968
Narcotic (BTM)
No

Other package sizes (2)

TRIOCAPS retard caps 12 pce
None None
GTIN: 7680334450165
Not in V1
None
None None
GTIN: None
Not in V1